CAH Q3 Deep Dive: Specialty Expansion, M&A Drive Strong Top-Line Growth
Update: 2025-10-31
Description
Cardinal Health's Q3 performance exceeded expectations with $64B revenue and $2.55 per share profit, leading to raised full-year guidance. Success attributed to strong demand in Pharmaceutical and Specialty Solutions, strategic acquisitions, and efficiency gains from automation. All segments grew, with specialty care expected to see double-digit growth. Investors welcome cost management and scalability, while risks include tariffs and integration expenses. The stock surged to $191 post-earnings, with focus on integrating Solaris Health and exploring opportunities in Nuclear and Precision Health, logistics, and generic drugs.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
